Reuters – A combination of three genetic abnormalities has a dramatic impact on how long prostate cancer patients are likely to live, researchers said on Wednesday, and gene tests could help doctors decide on the best treatments.

This entry was posted on Wednesday, January 27th, 2010 at 3:38 pm and is filed under Male Health. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.